Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD 20.48
+0.50 (2.50%)
Sep 5, 2025, 4:10 PM AEST
Neuren Pharmaceuticals Revenue
Neuren Pharmaceuticals had revenue of 28.28M AUD in the half year ending June 30, 2025, a decrease of -55.06%. This brings the company's revenue in the last twelve months to 218.86M, up 12.09% year-over-year. In the year 2024, Neuren Pharmaceuticals had annual revenue of 216.83M, down -6.51%.
Revenue (ttm)
218.86M
Revenue Growth
+12.09%
P/S Ratio
11.82
Revenue / Employee
27.36M
Employees
8
Market Cap
2.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 216.83M | -15.11M | -6.51% |
| Dec 31, 2023 | 231.94M | 216.53M | 1,404.46% |
| Dec 31, 2022 | 15.42M | 12.22M | 382.23% |
| Dec 31, 2021 | 3.20M | 2.48M | 345.89% |
| Dec 31, 2020 | 717.00K | 222.00K | 44.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Pro Medicus | 212.98M |
| Cochlear | 2.34B |
| Sonic Healthcare | 9.65B |
| Ramsay Health Care | 17.79B |
| Ansell | 3.06B |
| Telix Pharmaceuticals | 1.01B |
| Mesoblast | 26.23M |
Neuren Pharmaceuticals News
- 6 months ago - Neuren Pharmaceuticals Ltd (NURPF) (FY 2024) Earnings Call Highlights: Record Financial ... - GuruFocus
- 6 months ago - Full Year 2024 Neuren Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus